Syngene Appoints AlphaMetrix Biotech and LTF Labortechnik in Germany
News Jun 23, 2015
Syngene has announced that it has appointed AlphaMetrix Biotech and LTF-Labortechnik as its new distributors in Germany. Both will work closely with Syngene to ensure that German scientists have access to the latest systems and software for accurately imaging and analyzing a wide range of gels and Western blots.
AlphaMetrix Biotech and LTF-Labortechnik are established life science distributors, located near research hubs close to Frankfurt and Munich (respectively). Both have expertly trained staff with extensive knowledge of supplying and supporting gel documentation systems in major research institutes and pharmaceutical companies.
As part of Syngene’s drive to ensure that its portfolio of high-quality image analysis systems are accessible to German scientists, Syngene would like to expand further and is actively recruiting additional distributors with gel documentation expertise.
Heiner Sanders, General Manager at AlphaMetrix Biotech commented: “We are very pleased to work as a distributor for Syngene products in Germany. It is an incredibly good fit with our current portfolio of molecular biology equipment and will offer our customers a complete solution for their research needs.”
Noel Kändler, Managing Director at LTF-Labortechnik added: “Having visited Syngene, we know the firm offers an excellent range of products and software. Syngene also have well-trained staff, who have been very responsive to our requests and we’re looking forward to demonstrating the equipment’s outstanding imaging performance to German molecular biologists.”
Rob van den Broek, European Sales Manager for Syngene concluded: “Our systems are being used successfully by top laboratories in the UK and US to produce high quality results from their Western blot, 1-D and 2-D gel analysis. With the appointments of AlphaMetrix Biotech and LTF-Labortechnik, we are fortunate to have found well-respected life science distributors and they will make it quicker and easier for German scientists to assess this excellent technology in their own laboratories.”
Cellular Valve Structure Opens Up Potential Novel TherapiesNews
Biochemists have determined the detailed structure of a volume-regulated chloride channel. This cellular valve is activated in response to swelling to prevent the cell from bursting. The protein also plays an important role in the uptake of chemotherapeutics and the release of neurotransmitters after a stroke. The controlled regulation of its activity thus opens up a promising strategy for novel therapies.READ MORE
State-of-the-Art Tech Uncovers Potential Cancer Drug TargetsNews
In a new study based on mouse cells internationally leading protein researchers have identified several new potential targets using state-of-the-art mass spec technology, many of which could be employed for future treatment of different types of cancers and diseases.READ MORE